Singular Genomics Systems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	16.83	75.98	201.74	12.17	5.52
Short-Term Investments	157.71	170.31	138.17	15.23	40.7
Cash & Cash Equivalents	174.54	246.29	339.91	27.4	46.22
Cash Growth	-29.13%	-27.54%	1140.50%	-40.71%	-
Receivables	0.57	0.91	0	0	0
Inventory	13.57	18.22	3.01	0	0
Other Current Assets	3.55	3.01	4.84	0.17	0.24
Total Current Assets	192.23	268.43	347.76	27.57	46.46
Property, Plant & Equipment	71.49	56.68	6.07	2.37	1.61
Other Long-Term Assets	1.75	2.86	1.82	0.56	0.1
Total Long-Term Assets	73.24	59.54	7.89	2.93	1.72
Total Assets	265.47	327.98	355.65	30.5	48.17
Accounts Payable	2.59	3.1	2.35	0.43	0.56
Current Debt	7.76	6.32	0	0.93	0
Other Current Liabilities	7.94	4.7	4.4	2.34	0.55
Total Current Liabilities	18.29	14.12	6.74	3.69	1.11
Long-Term Debt	67.52	52.52	9.9	8.47	2.4
Other Long-Term Liabilities	0.65	1.02	2.83	0.71	0.17
Total Long-Term Liabilities	68.17	53.54	12.73	9.18	2.57
Total Liabilities	86.46	67.65	19.48	12.87	3.69
Total Debt	75.29	58.84	9.9	9.4	2.4
Debt Growth	27.95%	494.14%	5.42%	291.46%	-
Retained Earnings	-337.6	-242.78	-151.9	-53.13	-25.18
Comprehensive Income	0.16	-0.84	-0.14	0.02	0.01
Shareholders' Equity	179.01	260.32	336.17	-51.56	-24.73
Net Cash / Debt	99.25	187.44	330.01	18.01	43.82
Net Cash / Debt Growth	-47.05%	-43.20%	1732.76%	-58.91%	-
Net Cash Per Share	1.36	2.63	7.02	1.70	5.08
Working Capital	173.94	254.31	341.02	23.88	45.35
Book Value Per Share	2.46	3.66	7.15	-4.88	-2.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).